Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Pfizer, BioNTech lift market as COVID vaccine shows effectiveness » 11:13
11/09/20
11/09
11:13
11/09/20
11:13
WYNN

Wynn Resorts

$98.96 /

+18.88 (+23.58%)

, DIS

Disney

$139.03 /

+11.64 (+9.14%)

, ZM

Zoom Video

$421.59 /

-78.52 (-15.70%)

, PFE

Pfizer

$39.40 /

+3.005 (+8.26%)

, BNTX

BioNTech

$101.50 /

+9.63 (+10.48%)

, MRNA

Moderna

$77.00 /

+4.58 (+6.32%)

, AAL

American Airlines

$13.04 /

+1.58 (+13.79%)

, UAL

United Airlines

$39.69 /

+5 (+14.41%)

, DAL

Delta Air Lines

$35.10 /

+3.68 (+11.71%)

, JBLU

JetBlue

$14.74 /

+2.39 (+19.35%)

, LUV

Southwest

$44.80 /

+4.78 (+11.94%)

, RCL

Royal Caribbean

$72.35 /

+13.75 (+23.46%)

, NCLH

Norwegian Cruise Line

$20.63 /

+3.665 (+21.60%)

, CCL

Carnival

$17.97 /

+4.145 (+29.98%)

, MAR

Marriott

$115.33 /

+11.5 (+11.08%)

, PTON

Peloton

$107.07 /

-18.39 (-14.66%)

, NFLX

Netflix

$487.02 /

-27.59 (-5.36%)

, QDEL

Quidel

$193.11 /

-90.71 (-31.96%)

, FLGT

Fulgent Genetics

$31.34 /

-8.71 (-21.75%)

, FLDM

Fluidigm

$5.36 /

-2.21 (-29.19%)

, LMNX

Luminex

$22.05 /

-1.09 (-4.71%)

, VIVO

Meridian Bioscience

$16.31 /

-2.39 (-12.78%)

Shares of Pfizer (PFE)…

ShowHide Related Items >><<
ZM Zoom Video
$421.59 /

-78.52 (-15.70%)

WYNN Wynn Resorts
$98.96 /

+18.88 (+23.58%)

VIVO Meridian Bioscience
$16.31 /

-2.39 (-12.78%)

UAL United Airlines
$39.69 /

+5 (+14.41%)

RCL Royal Caribbean
$72.35 /

+13.75 (+23.46%)

QDEL Quidel
$193.11 /

-90.71 (-31.96%)

PTON Peloton
$107.07 /

-18.39 (-14.66%)

PFE Pfizer
$39.40 /

+3.005 (+8.26%)

NFLX Netflix
$487.02 /

-27.59 (-5.36%)

NCLH Norwegian Cruise Line
$20.63 /

+3.665 (+21.60%)

MRNA Moderna
$77.00 /

+4.58 (+6.32%)

MAR Marriott
$115.33 /

+11.5 (+11.08%)

LUV Southwest
$44.80 /

+4.78 (+11.94%)

LMNX Luminex
$22.05 /

-1.09 (-4.71%)

JBLU JetBlue
$14.74 /

+2.39 (+19.35%)

FLGT Fulgent Genetics
$31.34 /

-8.71 (-21.75%)

FLDM Fluidigm
$5.36 /

-2.21 (-29.19%)

DIS Disney
$139.03 /

+11.64 (+9.14%)

DAL Delta Air Lines
$35.10 /

+3.68 (+11.71%)

CCL Carnival
$17.97 /

+4.145 (+29.98%)

BNTX BioNTech
$101.50 /

+9.63 (+10.48%)

AAL American Airlines
$13.04 /

+1.58 (+13.79%)

WYNN Wynn Resorts
$98.96 /

+18.88 (+23.58%)

11/09/20 Credit Suisse
Wynn Resorts price target raised to $80 from $72 at Credit Suisse
11/06/20 Deutsche Bank
Wynn Resorts price target raised to $95 from $93 at Deutsche Bank
11/02/20 Deutsche Bank
Massachusetts order could impact Wynn, Penn and MGM, says Deutsche Bank
11/02/20
Fly Intel: Top five analyst upgrades
DIS Disney
$139.03 /

+11.64 (+9.14%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 RBC Capital
EPR Properties downgraded to Sector Perform from Outperform at RBC Capital
10/13/20 Morgan Stanley
Disney reorg 'leaves little doubt' about DTC commitment, says Morgan Stanley
10/13/20 Loop Capital
Disney upgraded to Buy from Hold at Loop Capital
ZM Zoom Video
$421.59 /

-78.52 (-15.70%)

10/26/20 Stifel
SAP news impact may be company-specific for software sector, says Stifel
10/21/20 Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
10/15/20 Morgan Stanley
Zoom Video meeting had 'no thesis changing announcements,' says Morgan Stanley
10/15/20 Bernstein
Zoom Video price target raised to $611 from $228 at Bernstein
PFE Pfizer
$39.40 /

+3.005 (+8.26%)

11/09/20 Chardan
Chardan sees important positive read-across for Moderna pipeline in Pfizer news
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
11/09/20 Piper Sandler
Pfizer vaccine data has positive read-through for Moderna, says Piper Sandler
10/23/20
Fly Intel: Pre-market Movers
BNTX BioNTech
$101.50 /

+9.63 (+10.48%)

10/29/20
Fly Intel: Top five analyst initiations
MRNA Moderna
$77.00 /

+4.58 (+6.32%)

10/08/20 Piper Sandler
Moderna regains rights to adult RSV vaccine mRNA-1172, Piper ups target to $136
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
AAL American Airlines
$13.04 /

+1.58 (+13.79%)

10/13/20
Fly Intel: Top five analyst downgrades
10/13/20 Susquehanna
American Airlines downgraded to Negative from Neutral at Susquehanna
09/02/20
Fly Intel: Top five analyst downgrades
09/02/20 Berenberg
Berenberg ups Southwest to Buy, cuts American to Sell amid airline rating shift
UAL United Airlines
$39.69 /

+5 (+14.41%)

10/12/20
Fly Intel: Top five analyst downgrades
10/12/20 Barclays
Barclays downgrades United Airlines on international exposure
10/12/20 Barclays
United Airlines downgraded to Equal Weight from Overweight at Barclays
10/07/20
Fly Intel: Top five analyst upgrades
DAL Delta Air Lines
$35.10 /

+3.68 (+11.71%)

10/14/20 Susquehanna
Delta Air Lines delivered on cost guidance, Susquehanna remains Positive
10/07/20 JPMorgan
Delta Air Lines price target raised to $51 from $45 at JPMorgan
09/18/20 Barclays
Delta Air Lines price target raised to $30 from $26 at Barclays
09/15/20 Seaport Global
Delta Air Lines initiated with a Buy at Seaport Global
JBLU JetBlue
$14.74 /

+2.39 (+19.35%)

10/07/20 JPMorgan
JPMorgan double upgrades JetBlue to Overweight on cost controls
10/07/20 JPMorgan
JetBlue upgraded to Overweight from Underweight at JPMorgan
09/08/20 Morgan Stanley
JetBlue initiated with an Overweight at Morgan Stanley
LUV Southwest
$44.80 /

+4.78 (+11.94%)

10/29/20 Citi
Southwest price target raised to $40 from $36 at Citi
10/23/20 UBS
Southwest price target raised to $52 from $48 at UBS
10/23/20 Credit Suisse
Southwest price target raised to $51 from $46 at Credit Suisse
10/07/20
Fly Intel: Top five analyst downgrades
RCL Royal Caribbean
$72.35 /

+13.75 (+23.46%)

10/30/20 Stifel
CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel
10/30/20 Deutsche Bank
Royal Caribbean price target raised to $46 from $43 at Deutsche Bank
10/16/20 Deutsche Bank
Deutsche sees Covid newsflow remaining drag on cruise stocks
10/15/20 Berenberg
Royal Caribbean price target raised to $60 from $45 at Berenberg
NCLH Norwegian Cruise Line
$20.63 /

+3.665 (+21.60%)

10/07/20 JPMorgan
Norwegian Cruise Line price target raised to $22 from $19 at JPMorgan
10/07/20 JPMorgan
Royal Caribbean price target raised to $79 from $67 at JPMorgan
CCL Carnival
$17.97 /

+4.145 (+29.98%)

10/07/20 JPMorgan
JPMorgan 'incrementally bullish' on cruise stocks, ups Carnival price target
MAR Marriott
$115.33 /

+11.5 (+11.08%)

11/09/20 Deutsche Bank
Marriott price target raised to $96 from $90 at Deutsche Bank
10/13/20 BMO Capital
Marriott upgraded to Market Perform from Underperform at BMO Capital
09/21/20 Citi
Marriott price target raised to $110 from $95 at Citi
08/17/20 Barclays
Marriott price target raised to $108 from $105 at Barclays
PTON Peloton
$107.07 /

-18.39 (-14.66%)

11/09/20 Baird
Peloton weakness a buying opportunity, says Baird
11/06/20 MKM Partners
Peloton price target raised to $110 from $90 at MKM Partners
11/06/20 Canaccord
Peloton price target raised to $150 from $120 at Canaccord
11/06/20 Raymond James
Peloton price target raised to $135 from $109 at Raymond James
NFLX Netflix
$487.02 /

-27.59 (-5.36%)

11/02/20 Loop Capital
Netflix price target raised to $650 from $600 at Loop Capital
10/30/20 Jefferies
Netflix U.S. price hike a 'bit early,' but not surprising, says Jefferies
10/30/20 Piper Sandler
Netflix price target raised to $643 from $630 at Piper Sandler
10/26/20 Wells Fargo
Netflix narrative to focus less on subs, more on profitability, says Wells Fargo
QDEL Quidel
$193.11 /

-90.71 (-31.96%)

10/30/20 JPMorgan
Quidel price target raised to $190 from $185 at JPMorgan
10/05/20 William Blair
Quidel emergency use news may be getting overlooked, says William Blair
10/02/20 Piper Sandler
Quidel recent pullback a buying opportunity, says Piper Sandler
FLGT Fulgent Genetics
$31.34 /

-8.71 (-21.75%)

09/25/20 Credit Suisse
Fulgent Genetics price target raised to $42 from $13 at Credit Suisse
09/03/20 Piper Sandler
Fulgent COVID-19 testing will 'remain robust,' says Piper Sandler
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
FLDM Fluidigm
$5.36 /

-2.21 (-29.19%)

10/19/20 Piper Sandler
Fluidigm test pact in Texas 'another validation,' says Piper Sandler
09/29/20 Piper Sandler
Piper Sandler would be buyers of Fluidigm given recent pullback
LMNX Luminex
$22.05 /

-1.09 (-4.71%)

11/06/20 Piper Sandler
Luminex's new product launches can drive long-term growth, says Piper Sandler
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
VIVO Meridian Bioscience
$16.31 /

-2.39 (-12.78%)

08/11/20 Piper Sandler
Meridian Bioscience assumed with an Overweight at Piper Sandler
ZM Zoom Video
$421.59 /

-78.52 (-15.70%)

WYNN Wynn Resorts
$98.96 /

+18.88 (+23.58%)

VIVO Meridian Bioscience
$16.31 /

-2.39 (-12.78%)

UAL United Airlines
$39.69 /

+5 (+14.41%)

RCL Royal Caribbean
$72.35 /

+13.75 (+23.46%)

QDEL Quidel
$193.11 /

-90.71 (-31.96%)

PTON Peloton
$107.07 /

-18.39 (-14.66%)

PFE Pfizer
$39.40 /

+3.005 (+8.26%)

NFLX Netflix
$487.02 /

-27.59 (-5.36%)

NCLH Norwegian Cruise Line
$20.63 /

+3.665 (+21.60%)

MRNA Moderna
$77.00 /

+4.58 (+6.32%)

MAR Marriott
$115.33 /

+11.5 (+11.08%)

LUV Southwest
$44.80 /

+4.78 (+11.94%)

LMNX Luminex
$22.05 /

-1.09 (-4.71%)

JBLU JetBlue
$14.74 /

+2.39 (+19.35%)

FLGT Fulgent Genetics
$31.34 /

-8.71 (-21.75%)

FLDM Fluidigm
$5.36 /

-2.21 (-29.19%)

DIS Disney
$139.03 /

+11.64 (+9.14%)

DAL Delta Air Lines
$35.10 /

+3.68 (+11.71%)

CCL Carnival
$17.97 /

+4.145 (+29.98%)

BNTX BioNTech
$101.50 /

+9.63 (+10.48%)

AAL American Airlines
$13.04 /

+1.58 (+13.79%)

  • 14
    Oct
  • 23
    Jul
  • 17
    Jul
  • 23
    Jun
  • 19
    May
  • 06
    May
  • 29
    Apr
  • 22
    Apr
  • 02
    Apr
  • 12
    Feb
  • 06
    Feb
  • 14
    Nov
ZM Zoom Video
$421.59 /

-78.52 (-15.70%)

WYNN Wynn Resorts
$98.96 /

+18.88 (+23.58%)

UAL United Airlines
$39.69 /

+5 (+14.41%)

RCL Royal Caribbean
$72.35 /

+13.75 (+23.46%)

QDEL Quidel
$193.11 /

-90.71 (-31.96%)

PTON Peloton
$107.07 /

-18.39 (-14.66%)

PFE Pfizer
$39.40 /

+3.005 (+8.26%)

NFLX Netflix
$487.02 /

-27.59 (-5.36%)

MRNA Moderna
$77.00 /

+4.58 (+6.32%)

MAR Marriott
$115.33 /

+11.5 (+11.08%)

LUV Southwest
$44.80 /

+4.78 (+11.94%)

JBLU JetBlue
$14.74 /

+2.39 (+19.35%)

FLDM Fluidigm
$5.36 /

-2.21 (-29.19%)

DIS Disney
$139.03 /

+11.64 (+9.14%)

DAL Delta Air Lines
$35.10 /

+3.68 (+11.71%)

CCL Carnival
$17.97 /

+4.145 (+29.98%)

BNTX BioNTech
$101.50 /

+9.63 (+10.48%)

AAL American Airlines
$13.04 /

+1.58 (+13.79%)

ZM Zoom Video
$421.59 /

-78.52 (-15.70%)

WYNN Wynn Resorts
$98.96 /

+18.88 (+23.58%)

UAL United Airlines
$39.69 /

+5 (+14.41%)

QDEL Quidel
$193.11 /

-90.71 (-31.96%)

PTON Peloton
$107.07 /

-18.39 (-14.66%)

PFE Pfizer
$39.40 /

+3.005 (+8.26%)

NFLX Netflix
$487.02 /

-27.59 (-5.36%)

NCLH Norwegian Cruise Line
$20.63 /

+3.665 (+21.60%)

MRNA Moderna
$77.00 /

+4.58 (+6.32%)

MAR Marriott
$115.33 /

+11.5 (+11.08%)

LUV Southwest
$44.80 /

+4.78 (+11.94%)

LMNX Luminex
$22.05 /

-1.09 (-4.71%)

JBLU JetBlue
$14.74 /

+2.39 (+19.35%)

FLGT Fulgent Genetics
$31.34 /

-8.71 (-21.75%)

FLDM Fluidigm
$5.36 /

-2.21 (-29.19%)

DIS Disney
$139.03 /

+11.64 (+9.14%)

DAL Delta Air Lines
$35.10 /

+3.68 (+11.71%)

BNTX BioNTech
$101.50 /

+9.63 (+10.48%)

AAL American Airlines
$13.04 /

+1.58 (+13.79%)

ZM Zoom Video
$421.59 /

-78.52 (-15.70%)

WYNN Wynn Resorts
$98.96 /

+18.88 (+23.58%)

UAL United Airlines
$39.69 /

+5 (+14.41%)

RCL Royal Caribbean
$72.35 /

+13.75 (+23.46%)

PTON Peloton
$107.07 /

-18.39 (-14.66%)

PFE Pfizer
$39.40 /

+3.005 (+8.26%)

NFLX Netflix
$487.02 /

-27.59 (-5.36%)

NCLH Norwegian Cruise Line
$20.63 /

+3.665 (+21.60%)

MRNA Moderna
$77.00 /

+4.58 (+6.32%)

MAR Marriott
$115.33 /

+11.5 (+11.08%)

LUV Southwest
$44.80 /

+4.78 (+11.94%)

JBLU JetBlue
$14.74 /

+2.39 (+19.35%)

FLGT Fulgent Genetics
$31.34 /

-8.71 (-21.75%)

FLDM Fluidigm
$5.36 /

-2.21 (-29.19%)

DIS Disney
$139.03 /

+11.64 (+9.14%)

DAL Delta Air Lines
$35.10 /

+3.68 (+11.71%)

CCL Carnival
$17.97 /

+4.145 (+29.98%)

BNTX BioNTech
$101.50 /

+9.63 (+10.48%)

AAL American Airlines
$13.04 /

+1.58 (+13.79%)

Recommendations
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler » 10:55
11/09/20
11/09
10:55
11/09/20
10:55
QDEL

Quidel

$194.04 /

-89.78 (-31.63%)

, PFE

Pfizer

$39.18 /

+2.78 (+7.64%)

, BNTX

BioNTech

$99.30 /

+7.43 (+8.09%)

, FLGT

Fulgent Genetics

$30.69 /

-9.36 (-23.37%)

, FLDM

Fluidigm

$5.21 /

-2.36 (-31.18%)

, LMNX

Luminex

$21.94 /

-1.2 (-5.19%)

, VIVO

Meridian Bioscience

$16.72 /

-1.98 (-10.59%)

Companies with COVID-19…

Companies with COVID-19 tests have sold off 30%-plus following positive vaccine news from Pfizer (PFE) and BioNTech (BNTX), Piper Sandler analyst Steven Mah tells investors in a research note. The analyst believes the selloff is an overreaction and presents a buying opportunity for "highly-differentiated testing companies" such as Quidel (QDEL), Fulgent Genetics (FLGT), Fluidigm (FLDM), Luminex (LMNX) and Meridian Bioscience (VIVO). Diagnostics remains the "primary front-line defense with the Biden Administration naming Testing the First Point of their Seven-Point COVID-19 Plan," says Mah. The analyst would be buyers of companies with COVID-19 testing exposure on today's pullback.

ShowHide Related Items >><<
VIVO Meridian Bioscience
$16.72 /

-1.98 (-10.59%)

QDEL Quidel
$194.04 /

-89.78 (-31.63%)

PFE Pfizer
$39.18 /

+2.78 (+7.64%)

LMNX Luminex
$21.94 /

-1.2 (-5.19%)

FLGT Fulgent Genetics
$30.69 /

-9.36 (-23.37%)

FLDM Fluidigm
$5.21 /

-2.36 (-31.18%)

BNTX BioNTech
$99.30 /

+7.43 (+8.09%)

QDEL Quidel
$194.04 /

-89.78 (-31.63%)

10/30/20 JPMorgan
Quidel price target raised to $190 from $185 at JPMorgan
10/05/20 William Blair
Quidel emergency use news may be getting overlooked, says William Blair
10/02/20 Piper Sandler
Quidel recent pullback a buying opportunity, says Piper Sandler
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
PFE Pfizer
$39.18 /

+2.78 (+7.64%)

11/09/20 Piper Sandler
Pfizer vaccine data has positive read-through for Moderna, says Piper Sandler
10/23/20
Fly Intel: Pre-market Movers
10/23/20 Piper Sandler
Ultragenyx deal with Solid Biosciences looks 'solid,' says Piper Sandler
10/23/20 Truist
Pfizer initiated with a Buy at Truist
BNTX BioNTech
$99.30 /

+7.43 (+8.09%)

10/29/20
Fly Intel: Top five analyst initiations
10/29/20 Commerzbank
BioNTech initiated with a Buy at Commerzbank
10/14/20 SVB Leerink
BioNTech price target raised to $69 from $62 at SVB Leerink
FLGT Fulgent Genetics
$30.69 /

-9.36 (-23.37%)

09/25/20 Credit Suisse
Fulgent Genetics price target raised to $42 from $13 at Credit Suisse
09/03/20 Piper Sandler
Fulgent COVID-19 testing will 'remain robust,' says Piper Sandler
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
FLDM Fluidigm
$5.21 /

-2.36 (-31.18%)

10/19/20 Piper Sandler
Fluidigm test pact in Texas 'another validation,' says Piper Sandler
09/29/20 Piper Sandler
Piper Sandler would be buyers of Fluidigm given recent pullback
LMNX Luminex
$21.94 /

-1.2 (-5.19%)

11/06/20 Piper Sandler
Luminex's new product launches can drive long-term growth, says Piper Sandler
08/18/20 Piper Sandler
Luminex assumed with an Overweight at Piper Sandler
VIVO Meridian Bioscience
$16.72 /

-1.98 (-10.59%)

08/11/20 Piper Sandler
Meridian Bioscience assumed with an Overweight at Piper Sandler
07/27/20 H.C. Wainwright
Meridian Bioscience initiated with a Buy at H.C. Wainwright
VIVO Meridian Bioscience
$16.72 /

-1.98 (-10.59%)

QDEL Quidel
$194.04 /

-89.78 (-31.63%)

PFE Pfizer
$39.18 /

+2.78 (+7.64%)

LMNX Luminex
$21.94 /

-1.2 (-5.19%)

FLGT Fulgent Genetics
$30.69 /

-9.36 (-23.37%)

FLDM Fluidigm
$5.21 /

-2.36 (-31.18%)

BNTX BioNTech
$99.30 /

+7.43 (+8.09%)

  • 23
    Jul
  • 06
    Feb
  • 14
    Nov
QDEL Quidel
$194.04 /

-89.78 (-31.63%)

PFE Pfizer
$39.18 /

+2.78 (+7.64%)

FLDM Fluidigm
$5.21 /

-2.36 (-31.18%)

BNTX BioNTech
$99.30 /

+7.43 (+8.09%)

QDEL Quidel
$194.04 /

-89.78 (-31.63%)

PFE Pfizer
$39.18 /

+2.78 (+7.64%)

LMNX Luminex
$21.94 /

-1.2 (-5.19%)

FLGT Fulgent Genetics
$30.69 /

-9.36 (-23.37%)

FLDM Fluidigm
$5.21 /

-2.36 (-31.18%)

BNTX BioNTech
$99.30 /

+7.43 (+8.09%)

PFE Pfizer
$39.18 /

+2.78 (+7.64%)

FLGT Fulgent Genetics
$30.69 /

-9.36 (-23.37%)

FLDM Fluidigm
$5.21 /

-2.36 (-31.18%)

BNTX BioNTech
$99.30 /

+7.43 (+8.09%)

On The Fly
Fly Intel: Pre-market Movers » 09:03
11/09/20
11/09
09:03
11/09/20
09:03
PFE

Pfizer

$36.40 /

+0.005 (+0.01%)

, BNTX

BioNTech

$91.98 /

-0.04 (-0.04%)

, AAL

American Airlines

$11.46 /

-0.12 (-1.04%)

, UAL

United Airlines

$34.69 /

-0.67 (-1.89%)

, LUV

Southwest

$40.02 /

-1.02 (-2.49%)

, DIS

Disney

$127.43 /

+0.37 (+0.29%)

, MCD

McDonald's

$216.32 /

-0.13 (-0.06%)

, TSQ

Townsquare Media

$4.96 /

+0.25 (+5.31%)

, NBEV

NewAge

$3.24 /

+0.235 (+7.83%)

, IVR

Invesco Mortgage

$2.87 /

+0.015 (+0.53%)

, AVDL

Avadel Pharmaceuticals

$5.45 /

-0.24 (-4.22%)

, PTE

PolarityTE

$0.96 /

+0.0503 (+5.53%)

, ACB

Aurora Cannabis

$9.75 /

+3.49 (+55.75%)

, KOS

Kosmos

$0.99 /

-0.05 (-4.81%)

, CGC

Canopy Growth

$23.50 /

+2.3 (+10.85%)

, ZM

Zoom Video

$499.84 /

+3.325 (+0.67%)

, NFLX

Netflix

$514.78 /

+0.835 (+0.16%)

, PTON

Peloton

$125.20 /

-1.53 (-1.21%)

, BIIB

Biogen

$328.93 /

+ (+0.00%)

, QDEL

Quidel

$283.71 /

+1.85 (+0.66%)

, CCL

Carnival

$13.83 /

-0.35 (-2.47%)

, RCL

Royal Caribbean

$58.56 /

-1.61 (-2.68%)

, NCLH

Norwegian Cruise Line

$16.97 /

-0.29 (-1.68%)

Check out this morning's…

ShowHide Related Items >><<
ZM Zoom Video
$499.84 /

+3.325 (+0.67%)

UAL United Airlines
$34.69 /

-0.67 (-1.89%)

TSQ Townsquare Media
$4.96 /

+0.25 (+5.31%)

RCL Royal Caribbean
$58.56 /

-1.61 (-2.68%)

QDEL Quidel
$283.71 /

+1.85 (+0.66%)

PTON Peloton
$125.20 /

-1.53 (-1.21%)

PTE PolarityTE
$0.96 /

+0.0503 (+5.53%)

PFE Pfizer
$36.40 /

+0.005 (+0.01%)

NFLX Netflix
$514.78 /

+0.835 (+0.16%)

NCLH Norwegian Cruise Line
$16.97 /

-0.29 (-1.68%)

NBEV NewAge
$3.24 /

+0.235 (+7.83%)

MCD McDonald's
$216.32 /

-0.13 (-0.06%)

LUV Southwest
$40.02 /

-1.02 (-2.49%)

KOS Kosmos
$0.99 /

-0.05 (-4.81%)

IVR Invesco Mortgage
$2.87 /

+0.015 (+0.53%)

DIS Disney
$127.43 /

+0.37 (+0.29%)

CGC Canopy Growth
$23.50 /

+2.3 (+10.85%)

CCL Carnival
$13.83 /

-0.35 (-2.47%)

BNTX BioNTech
$91.98 /

-0.04 (-0.04%)

BIIB Biogen
$328.93 /

+ (+0.00%)

AVDL Avadel Pharmaceuticals
$5.45 /

-0.24 (-4.22%)

ACB Aurora Cannabis
$9.75 /

+3.49 (+55.75%)

AAL American Airlines
$11.46 /

-0.12 (-1.04%)

PFE Pfizer
$36.40 /

+0.005 (+0.01%)

10/23/20
Fly Intel: Pre-market Movers
10/23/20 Piper Sandler
Ultragenyx deal with Solid Biosciences looks 'solid,' says Piper Sandler
10/23/20 Truist
Pfizer initiated with a Buy at Truist
10/14/20 SVB Leerink
BioNTech price target raised to $69 from $62 at SVB Leerink
BNTX BioNTech
$91.98 /

-0.04 (-0.04%)

10/29/20
Fly Intel: Top five analyst initiations
10/29/20 Commerzbank
BioNTech initiated with a Buy at Commerzbank
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
AAL American Airlines
$11.46 /

-0.12 (-1.04%)

10/13/20
Fly Intel: Top five analyst downgrades
10/13/20 Susquehanna
American Airlines downgraded to Negative from Neutral at Susquehanna
09/02/20
Fly Intel: Top five analyst downgrades
09/02/20 Berenberg
Berenberg ups Southwest to Buy, cuts American to Sell amid airline rating shift
UAL United Airlines
$34.69 /

-0.67 (-1.89%)

10/12/20
Fly Intel: Top five analyst downgrades
10/12/20 Barclays
Barclays downgrades United Airlines on international exposure
10/12/20 Barclays
United Airlines downgraded to Equal Weight from Overweight at Barclays
10/07/20
Fly Intel: Top five analyst upgrades
LUV Southwest
$40.02 /

-1.02 (-2.49%)

10/29/20 Citi
Southwest price target raised to $40 from $36 at Citi
10/23/20 UBS
Southwest price target raised to $52 from $48 at UBS
10/23/20 Credit Suisse
Southwest price target raised to $51 from $46 at Credit Suisse
10/07/20
Fly Intel: Top five analyst downgrades
DIS Disney
$127.43 /

+0.37 (+0.29%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 RBC Capital
EPR Properties downgraded to Sector Perform from Outperform at RBC Capital
10/13/20 Morgan Stanley
Disney reorg 'leaves little doubt' about DTC commitment, says Morgan Stanley
10/13/20 Loop Capital
Disney upgraded to Buy from Hold at Loop Capital
MCD McDonald's
$216.32 /

-0.13 (-0.06%)

11/03/20 RBC Capital
McDonald's price target raised to $245 from $220 at RBC Capital
10/30/20 Stephens
Checks point to SSS slow-down in U.S. at both McDonald's, Wendy's, says Stephens
10/20/20 JPMorgan
McDonald's price target raised to $220 from $205 at JPMorgan
10/16/20 Longbow
McDonald's U.S. comps tracking well ahead of expectations, says Longbow
TSQ Townsquare Media
$4.96 /

+0.25 (+5.31%)

04/14/20 Barrington
Townsquare Media downgraded to Market Perform at Barrington
04/14/20 Barrington
Townsquare Media downgraded to Market Perform from Outperform at Barrington
NBEV NewAge
$3.24 /

+0.235 (+7.83%)

07/21/20 Alliance Global Partners
New Age Beverages price target raised to $5 from $3.50 at Alliance Global
04/14/20 Alliance Global Partners
New Age Beverages at Alliance Global Partners
03/11/20 Compass Point
New Age Beverages price target lowered to $4 from $9 at Compass Point
IVR Invesco Mortgage
$2.87 /

+0.015 (+0.53%)

06/30/20 BofA
Invesco Mortgage initiated with an Underperform at BofA
06/09/20 Barclays
Invesco Mortgage price target raised to $4 from $2 at Barclays
05/27/20 Barclays
Invesco Mortgage downgraded to Underweight on book value erosion at Barclays
05/27/20 Barclays
Invesco Mortgage downgraded to Underweight from Equal Weight at Barclays
AVDL Avadel Pharmaceuticals
$5.45 /

-0.24 (-4.22%)

08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
07/31/20
Fly Intel: Top five analyst initiations
07/30/20 Oppenheimer
Avadel Pharmaceuticals initiated with an Outperform at Oppenheimer
PTE PolarityTE
$0.96 /

+0.0503 (+5.53%)

05/04/20 H.C. Wainwright
PolarityTE downgraded to Neutral from Buy at H.C. Wainwright
05/01/20 Oppenheimer
PolarityTE downgraded to Perform on limited visibility at Oppenheimer
05/01/20 Oppenheimer
PolarityTE downgraded to Perform from Outperform at Oppenheimer
04/20/20 Oppenheimer
Avita Medical initiated with an Outperform at Oppenheimer
ACB Aurora Cannabis
$9.75 /

+3.49 (+55.75%)

10/28/20 Stifel
Aurora Cannabis price target lowered to C$3.60 from C$10.50 at Stifel
10/27/20 Cantor Fitzgerald
Aurora Cannabis downgraded to Neutral from Overweight at Cantor Fitzgerald
10/27/20 Cantor Fitzgerald
Aurora Cannabis downgraded to Neutral from Overweight at Cantor Fitzgerald
09/24/20 CIBC
Aurora Cannabis price target lowered to C$12 from C$20 at CIBC
KOS Kosmos
$0.99 /

-0.05 (-4.81%)

08/07/20 Renaissance Capital
Kosmos upgraded to Buy from Hold at Renaissance Capital
05/14/20 Goldman Sachs
Kosmos downgraded to Neutral from Buy at Goldman Sachs
05/13/20 Berenberg
Kosmos price target lowered to $3.45 from $3.60 at Berenberg
05/13/20 RBC Capital
Kosmos upgraded to Sector Perform from Underperform at RBC Capital
CGC Canopy Growth
$23.50 /

+2.3 (+10.85%)

08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
08/11/20 Canaccord
Canopy Growth price target raised to C$22 from C$21 at Canaccord
07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
06/24/20 Cantor Fitzgerald
Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald
ZM Zoom Video
$499.84 /

+3.325 (+0.67%)

10/26/20 Stifel
SAP news impact may be company-specific for software sector, says Stifel
10/21/20 Morgan Stanley
Slack downgraded to Underweight on rising competitive risk at Morgan Stanley
10/15/20 Morgan Stanley
Zoom Video meeting had 'no thesis changing announcements,' says Morgan Stanley
10/15/20 Bernstein
Zoom Video price target raised to $611 from $228 at Bernstein
NFLX Netflix
$514.78 /

+0.835 (+0.16%)

11/02/20 Loop Capital
Netflix price target raised to $650 from $600 at Loop Capital
10/30/20 Jefferies
Netflix U.S. price hike a 'bit early,' but not surprising, says Jefferies
10/30/20 Piper Sandler
Netflix price target raised to $643 from $630 at Piper Sandler
10/26/20 Wells Fargo
Netflix narrative to focus less on subs, more on profitability, says Wells Fargo
PTON Peloton
$125.20 /

-1.53 (-1.21%)

11/09/20 Baird
Peloton weakness a buying opportunity, says Baird
11/06/20 MKM Partners
Peloton price target raised to $110 from $90 at MKM Partners
11/06/20 Canaccord
Peloton price target raised to $150 from $120 at Canaccord
11/06/20 Raymond James
Peloton price target raised to $135 from $109 at Raymond James
BIIB Biogen
$328.93 /

+ (+0.00%)

11/09/20 RBC Capital
Biogen price target lowered to $244 from $263 at RBC Capital
11/09/20 JPMorgan
Biogen approval chances in Alzheimer's 'in serious jeopardy,' says JPMorgan
11/09/20 Jefferies
Jefferies says 'still a chance' for FDA to approve Biogen's aducanumab
11/09/20 Citi
Citi sees difficulties with FDA approving Biogen Alzheimer's drug
QDEL Quidel
$283.71 /

+1.85 (+0.66%)

10/30/20 JPMorgan
Quidel price target raised to $190 from $185 at JPMorgan
10/05/20 William Blair
Quidel emergency use news may be getting overlooked, says William Blair
10/02/20 Piper Sandler
Quidel recent pullback a buying opportunity, says Piper Sandler
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
CCL Carnival
$13.83 /

-0.35 (-2.47%)

10/30/20 Stifel
CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel
10/16/20 Deutsche Bank
Deutsche sees Covid newsflow remaining drag on cruise stocks
10/07/20 JPMorgan
Royal Caribbean price target raised to $79 from $67 at JPMorgan
10/07/20 JPMorgan
JPMorgan 'incrementally bullish' on cruise stocks, ups Carnival price target
RCL Royal Caribbean
$58.56 /

-1.61 (-2.68%)

10/30/20 Deutsche Bank
Royal Caribbean price target raised to $46 from $43 at Deutsche Bank
10/15/20 Berenberg
Royal Caribbean price target raised to $60 from $45 at Berenberg
NCLH Norwegian Cruise Line
$16.97 /

-0.29 (-1.68%)

10/07/20 JPMorgan
Norwegian Cruise Line price target raised to $22 from $19 at JPMorgan
ZM Zoom Video
$499.84 /

+3.325 (+0.67%)

UAL United Airlines
$34.69 /

-0.67 (-1.89%)

TSQ Townsquare Media
$4.96 /

+0.25 (+5.31%)

RCL Royal Caribbean
$58.56 /

-1.61 (-2.68%)

QDEL Quidel
$283.71 /

+1.85 (+0.66%)

PTON Peloton
$125.20 /

-1.53 (-1.21%)

PTE PolarityTE
$0.96 /

+0.0503 (+5.53%)

PFE Pfizer
$36.40 /

+0.005 (+0.01%)

NFLX Netflix
$514.78 /

+0.835 (+0.16%)

NCLH Norwegian Cruise Line
$16.97 /

-0.29 (-1.68%)

NBEV NewAge
$3.24 /

+0.235 (+7.83%)

MCD McDonald's
$216.32 /

-0.13 (-0.06%)

LUV Southwest
$40.02 /

-1.02 (-2.49%)

KOS Kosmos
$0.99 /

-0.05 (-4.81%)

IVR Invesco Mortgage
$2.87 /

+0.015 (+0.53%)

DIS Disney
$127.43 /

+0.37 (+0.29%)

CGC Canopy Growth
$23.50 /

+2.3 (+10.85%)

CCL Carnival
$13.83 /

-0.35 (-2.47%)

BNTX BioNTech
$91.98 /

-0.04 (-0.04%)

BIIB Biogen
$328.93 /

+ (+0.00%)

AVDL Avadel Pharmaceuticals
$5.45 /

-0.24 (-4.22%)

ACB Aurora Cannabis
$9.75 /

+3.49 (+55.75%)

AAL American Airlines
$11.46 /

-0.12 (-1.04%)

  • 14
    Oct
  • 23
    Jul
  • 17
    Jul
  • 23
    Jun
  • 06
    May
  • 29
    Apr
  • 29
    Apr
  • 22
    Apr
  • 02
    Apr
  • 12
    Feb
  • 06
    Feb
  • 04
    Feb
ZM Zoom Video
$499.84 /

+3.325 (+0.67%)

UAL United Airlines
$34.69 /

-0.67 (-1.89%)

QDEL Quidel
$283.71 /

+1.85 (+0.66%)

PTON Peloton
$125.20 /

-1.53 (-1.21%)

PFE Pfizer
$36.40 /

+0.005 (+0.01%)

NFLX Netflix
$514.78 /

+0.835 (+0.16%)

MCD McDonald's
$216.32 /

-0.13 (-0.06%)

LUV Southwest
$40.02 /

-1.02 (-2.49%)

DIS Disney
$127.43 /

+0.37 (+0.29%)

CCL Carnival
$13.83 /

-0.35 (-2.47%)

BNTX BioNTech
$91.98 /

-0.04 (-0.04%)

BIIB Biogen
$328.93 /

+ (+0.00%)

ACB Aurora Cannabis
$9.75 /

+3.49 (+55.75%)

AAL American Airlines
$11.46 /

-0.12 (-1.04%)

ZM Zoom Video
$499.84 /

+3.325 (+0.67%)

UAL United Airlines
$34.69 /

-0.67 (-1.89%)

RCL Royal Caribbean
$58.56 /

-1.61 (-2.68%)

QDEL Quidel
$283.71 /

+1.85 (+0.66%)

PTON Peloton
$125.20 /

-1.53 (-1.21%)

PFE Pfizer
$36.40 /

+0.005 (+0.01%)

NFLX Netflix
$514.78 /

+0.835 (+0.16%)

NCLH Norwegian Cruise Line
$16.97 /

-0.29 (-1.68%)

NBEV NewAge
$3.24 /

+0.235 (+7.83%)

MCD McDonald's
$216.32 /

-0.13 (-0.06%)

KOS Kosmos
$0.99 /

-0.05 (-4.81%)

IVR Invesco Mortgage
$2.87 /

+0.015 (+0.53%)

DIS Disney
$127.43 /

+0.37 (+0.29%)

CCL Carnival
$13.83 /

-0.35 (-2.47%)

BNTX BioNTech
$91.98 /

-0.04 (-0.04%)

BIIB Biogen
$328.93 /

+ (+0.00%)

ACB Aurora Cannabis
$9.75 /

+3.49 (+55.75%)

AAL American Airlines
$11.46 /

-0.12 (-1.04%)

BIIB Biogen
$328.93 /

+ (+0.00%)

ZM Zoom Video
$499.84 /

+3.325 (+0.67%)

UAL United Airlines
$34.69 /

-0.67 (-1.89%)

RCL Royal Caribbean
$58.56 /

-1.61 (-2.68%)

PTON Peloton
$125.20 /

-1.53 (-1.21%)

PTE PolarityTE
$0.96 /

+0.0503 (+5.53%)

PFE Pfizer
$36.40 /

+0.005 (+0.01%)

NFLX Netflix
$514.78 /

+0.835 (+0.16%)

NCLH Norwegian Cruise Line
$16.97 /

-0.29 (-1.68%)

NBEV NewAge
$3.24 /

+0.235 (+7.83%)

MCD McDonald's
$216.32 /

-0.13 (-0.06%)

LUV Southwest
$40.02 /

-1.02 (-2.49%)

IVR Invesco Mortgage
$2.87 /

+0.015 (+0.53%)

DIS Disney
$127.43 /

+0.37 (+0.29%)

CGC Canopy Growth
$23.50 /

+2.3 (+10.85%)

CCL Carnival
$13.83 /

-0.35 (-2.47%)

BNTX BioNTech
$91.98 /

-0.04 (-0.04%)

BIIB Biogen
$328.93 /

+ (+0.00%)

ACB Aurora Cannabis
$9.75 /

+3.49 (+55.75%)

AAL American Airlines
$11.46 /

-0.12 (-1.04%)

Over a month ago
Recommendations
Quidel price target raised to $190 from $185 at JPMorgan » 08:17
10/30/20
10/30
08:17
10/30/20
08:17
QDEL

Quidel

$269.26 /

+5.31 (+2.01%)

JPMorgan analyst Tycho…

JPMorgan analyst Tycho Peterson raised the firm's price target on Quidel to $190 from $185 and keeps an Underweight rating on the shares following the company's Q3 results. The analyst says the beat was largely expected and that sustainability of the Sofia Antigen COVID-19 test remains the main question.

ShowHide Related Items >><<
QDEL Quidel
$269.26 /

+5.31 (+2.01%)

QDEL Quidel
$269.26 /

+5.31 (+2.01%)

10/05/20 William Blair
Quidel emergency use news may be getting overlooked, says William Blair
10/02/20 Piper Sandler
Quidel recent pullback a buying opportunity, says Piper Sandler
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/28/20 Piper Sandler
Quidel pullback on Abbott approval a buying opportunity, says Piper Sandler
QDEL Quidel
$269.26 /

+5.31 (+2.01%)

QDEL Quidel
$269.26 /

+5.31 (+2.01%)

QDEL Quidel
$269.26 /

+5.31 (+2.01%)

Earnings
Quidel reports Q3 adjusted EPS $5.78, consensus $4.75M » 16:42
10/29/20
10/29
16:42
10/29/20
16:42
QDEL

Quidel

$269.26 /

+5.31 (+2.01%)

Reports Q3 revenue…

Reports Q3 revenue $476.1M, consensus $450.39M. "The entire Quidel Team has risen to the challenge of this pandemic," Mr. Bryant added. "We were the first to develop and scale a rapid antigen test that democratized COVID-19 testing by providing affordable, highly accurate results in minutes at diverse points of care in tens of thousands of communities throughout the United States. As we enter both Q4 and flu season, Quidel is once again extending our innovation leadership with the first FDA-authorized 'ABC' rapid antigen test capable of detecting and distinguishing between Influenza A + B and COVID-19 from a single nasal swab in just 15 minutes. This real-time diagnostic tool will significantly enhance medical effectiveness in treating and containing the dangerous twin pandemic of COVID-19 and virulent flu."

ShowHide Related Items >><<
QDEL Quidel
$269.26 /

+5.31 (+2.01%)

QDEL Quidel
$269.26 /

+5.31 (+2.01%)

10/05/20 William Blair
Quidel emergency use news may be getting overlooked, says William Blair
10/02/20 Piper Sandler
Quidel recent pullback a buying opportunity, says Piper Sandler
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/28/20 Piper Sandler
Quidel pullback on Abbott approval a buying opportunity, says Piper Sandler
QDEL Quidel
$269.26 /

+5.31 (+2.01%)

QDEL Quidel
$269.26 /

+5.31 (+2.01%)

QDEL Quidel
$269.26 /

+5.31 (+2.01%)

Hot Stocks
Quidel director sells 11.7K shares of common stock » 19:31
10/14/20
10/14
19:31
10/14/20
19:31
QDEL

Quidel

$270.10 /

-4.21 (-1.53%)

In a regulatory filing,…

In a regulatory filing, Quidel disclosed that its director Mary Polan sold 11.7K shares of common stock on October 12 in a total transaction size of $3.24M. The holding represents about 51% of her total owned.

ShowHide Related Items >><<
QDEL Quidel
$270.10 /

-4.21 (-1.53%)

QDEL Quidel
$270.10 /

-4.21 (-1.53%)

10/05/20 William Blair
Quidel emergency use news may be getting overlooked, says William Blair
10/02/20 Piper Sandler
Quidel recent pullback a buying opportunity, says Piper Sandler
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/28/20 Piper Sandler
Quidel pullback on Abbott approval a buying opportunity, says Piper Sandler
QDEL Quidel
$270.10 /

-4.21 (-1.53%)

QDEL Quidel
$270.10 /

-4.21 (-1.53%)

QDEL Quidel
$270.10 /

-4.21 (-1.53%)

Recommendations
Quidel emergency use news may be getting overlooked, says William Blair » 09:03
10/05/20
10/05
09:03
10/05/20
09:03
QDEL

Quidel

$235.48 /

+9.94 (+4.41%)

Given the news cycle over…

Given the news cycle over the weekend with President Trump in the hospital, some "may have either missed the news, saw it but did not pay attention, or may not appreciate what this could mean for the company," William Blair analyst Brian Weinstein tells investors in a research note after Quidel announced Friday night it had notice of FDA Emergency Use Authorization for its combo influenza plus SARS-CoV-2 antigen test. Having a rapid antigen product that can simultaneously distinguish between influenza A, B, and COVID-19 is value creating for patients, clinicians, and the company as we are now in the 2020-2021 influenza season, says the analyst. Weinstein expects testing demand for such a test to be "robust, even if confirmed influenza cases are down." Many people who would not ordinarily get tests and those who may just have seasonal respiratory viruses other than influenza will look for confirmation they have neither influenza nor COVID-19, says Weinstein. He expects Quidel's price for the product to be about a 50% higher than the stand-alone COVID-19 assay. The analyst keeps an Outperform rating on Quidel.

ShowHide Related Items >><<
QDEL Quidel
$235.48 /

+9.94 (+4.41%)

QDEL Quidel
$235.48 /

+9.94 (+4.41%)

10/02/20 Piper Sandler
Quidel recent pullback a buying opportunity, says Piper Sandler
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/28/20 Piper Sandler
Quidel pullback on Abbott approval a buying opportunity, says Piper Sandler
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
QDEL Quidel
$235.48 /

+9.94 (+4.41%)

QDEL Quidel
$235.48 /

+9.94 (+4.41%)

QDEL Quidel
$235.48 /

+9.94 (+4.41%)

Hot Stocks
Quidel receives Emergency Use Authorization from FDA for new Covid test » 08:58
10/05/20
10/05
08:58
10/05/20
08:58
QDEL

Quidel

$235.48 /

+9.94 (+4.41%)

Quidel announced Friday…

Quidel announced Friday night that it has received Emergency Use Authorization from the Food and Drug Administration to market its Sofia 2 Flu + SARS Antigen FIA, a rapid point-of-care test to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid, simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A and influenza B in direct nasopharyngeal and nasal swab specimens from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider within the first five days of the onset of symptoms. The new Sofia 2 Flu + SARS Antigen FIA "offers excellent performance for SARS-2 (95.2% PPA versus PCR and 100% NPA versus PCR), as well as for Influenza A (90% sensitivity versus culture and 95% specificity versus culture) and Influenza B (89% sensitivity versus culture and 96% specificity versus culture) in nasal swabs," the company said in a statement. Quidel's new Sofia test "delivers a fast, highly accurate result for all three viruses from one nasal swab (or nasopharyngeal swab) sample in just 15 minutes, providing critical answers to patients and healthcare workers alike," it added.

ShowHide Related Items >><<
QDEL Quidel
$235.48 /

+9.94 (+4.41%)

QDEL Quidel
$235.48 /

+9.94 (+4.41%)

10/02/20 Piper Sandler
Quidel recent pullback a buying opportunity, says Piper Sandler
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/28/20 Piper Sandler
Quidel pullback on Abbott approval a buying opportunity, says Piper Sandler
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
QDEL Quidel
$235.48 /

+9.94 (+4.41%)

QDEL Quidel
$235.48 /

+9.94 (+4.41%)

QDEL Quidel
$235.48 /

+9.94 (+4.41%)

Recommendations
Quidel recent pullback a buying opportunity, says Piper Sandler » 05:04
10/02/20
10/02
05:04
10/02/20
05:04
QDEL

Quidel

$225.54 /

+5.32 (+2.42%)

Piper Sandler analyst…

Piper Sandler analyst Steven Mah is "pleased" with Quidel's positive pre announcement and recent wins with the Pac-12 and Big-10. COVID-19 testing will "remain durable for the coming years (even with a vaccine) and the market is large enough for multiple players," Mah tells investors in a research note. He believes Quidel can capture $1.08B and $1.58B of COVID-19 revenue in 2020 and 2021, respectively, up from prior COVID-19 estimates of $650M and $1.15B. The analyst would be buyers given the stock's recent pullback and keeps an Overweight rating on the name with a $360 price target.

ShowHide Related Items >><<
QDEL Quidel
$225.54 /

+5.32 (+2.42%)

QDEL Quidel
$225.54 /

+5.32 (+2.42%)

08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/28/20 Piper Sandler
Quidel pullback on Abbott approval a buying opportunity, says Piper Sandler
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
08/27/20 Goldman Sachs
Abbott test's sensitivity, low price 'positive surprises,' says Goldman Sachs
QDEL Quidel
$225.54 /

+5.32 (+2.42%)

QDEL Quidel
$225.54 /

+5.32 (+2.42%)

QDEL Quidel
$225.54 /

+5.32 (+2.42%)

Earnings
Quidel sees Q3 revenue $475M-$477M, consensus$ 394.28M » 09:08
10/01/20
10/01
09:08
10/01/20
09:08
QDEL

Quidel

$219.64 /

+4.3 (+2.00%)

"The entire team at…

"The entire team at Quidel has truly risen to the challenge of the COVID-19 pandemic, producing and shipping millions of tests to those with the greatest need, and further democratizing testing by providing affordable rapid testing to tens of thousands of communities throughout the United States. We are proud of the leading role we are playing to slow the spread of disease and, ultimately, get Americans back to work," said Douglas Bryant, president and chief executive officer of Quidel Corporation. "Moving forward, we expect even greater success in augmenting our supply chains and production for our COVID-19 diagnostic products, resulting in $800 million or more in revenue in our final quarter of 2020." Quidel's management team will hold a virtual Investor Day presentation on November 12, 2020 beginning at 8:00 am Pacific Time with a question-and-answer session scheduled immediately following the management presentation.

ShowHide Related Items >><<
QDEL Quidel
$219.64 /

+4.3 (+2.00%)

QDEL Quidel
$219.64 /

+4.3 (+2.00%)

08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/28/20 Piper Sandler
Quidel pullback on Abbott approval a buying opportunity, says Piper Sandler
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
08/27/20 Goldman Sachs
Abbott test's sensitivity, low price 'positive surprises,' says Goldman Sachs
QDEL Quidel
$219.64 /

+4.3 (+2.00%)

QDEL Quidel
$219.64 /

+4.3 (+2.00%)

QDEL Quidel
$219.64 /

+4.3 (+2.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.